ARAY Financials: Accuray Inc AI Analysis

Home

Stock

ARAY

Financials

ARAY Financial

Accuray Inc

$0.41

6.81%

$0.02

At close: Apr 02, 16:00:00 GMT-4

$0.41

Pre-market: Apr 06, 06:36:28 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.3888

Open

$0.3929

Day's Range

$0.377 - $0.4224

52 week range

$0.33 - $2.1

Volume

1.3M

Avg.Volume

1.1M

Dividend yield

EPS (TTM)

-0.30

Market Cap

$49.3M

What is ARAY?

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

ARAY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	436	458	446	447	429	396
Revenue Growth (YoY)	-4%	3%	0%	4%	8%	4%
Cost of Revenue	315	311	303	293	270	236
Gross Profit	121	146	143	154	160	159
Selling, General & Admin	86	91	91	94	94	84
Research & Development	44	47	48	57	57	52
Operating Expenses	130	139	140	151	151	137
Other Non Operating Income (Expenses)	0	0	0	0	0	1
Pretax Income	-33	1	-11	-6	-2	-4
Income Tax Expense	2	2	3	2	3	1
Net Income	-35	-1	-15	-9	-5	-6
Net Income Growth	775%	-93%	67%	80%	-17%	-300%
Shares Outstanding (Diluted)	120.97	102.76	98.27	94.9	92.1	92
Shares Change (YoY)	17%	5%	4%	3%	0%	2%
EPS (Diluted)	-0.29	-0.01	-0.15	-0.1	-0.06	-0.07
EPS Growth	564%	-90%	57.99%	67%	-14%	-275%
Free Cash Flow	-2	-1	-15	2	-7	36
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	27.75%	31.87%	32.06%	34.45%	37.29%	40.15%
Operating Margin	-1.83%	1.52%	0.67%	0.44%	1.86%	5.55%
Profit Margin	-8.02%	-0.21%	-3.36%	-2.01%	-1.16%	-1.51%
Free Cash Flow Margin	-0.45%	-0.21%	-3.36%	0.44%	-1.63%	9.09%
EBITDA	-1	13	8	6	13	28
EBITDA Margin	-0.22%	2.83%	1.79%	1.34%	3.03%	7.07%
D&A For EBITDA	7	6	5	4	5	6
EBIT	-8	7	3	2	8	22
EBIT Margin	-1.83%	1.52%	0.67%	0.44%	1.86%	5.55%
Effective Tax Rate	-6.06%	200%	-27.27%	-33.33%	-150%	-25%

Follow-Up Questions

What are Accuray Inc's key financial statements?



According to the latest financial statement (Form-10K), Accuray Inc has a total asset of $470, Net loss of $-1

What are the key financial ratios for ARAY?



Accuray Inc's Current ratio is 1.2, has a Net margin is -0.21, sales per share of $4.45.

How is Accuray Inc's revenue broken down by segment or geography?



Accuray Inc largest revenue segment is Oncology Systems Products, at a revenue of 234,164,000 in the most earnings release.For geography, Europe, Middle East, India and Africa is the primary market for Accuray Inc, at a revenue of 168,611,000.

Is Accuray Inc profitable?



no, according to the latest financial statements, Accuray Inc has a net loss of $-1

Does Accuray Inc have any liabilities?



yes, Accuray Inc has liability of 389

How many outstanding shares for Accuray Inc?



Accuray Inc has a total outstanding shares of 112.64

Accuray Inc (ARAY) Financial

ARAY Stock Price Chart